Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel
A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate.
FDA clears new AI model for pulmonary hypertension
The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.
Patient injected with acid instead of saline earns undisclosed settlement
The disturbing case highlights a series of process errors and cost-cutting measures that ultimately led to the “never event” accident.
‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight
The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.
Catheter-based treatment linked to major benefits for intermediate-risk PE
New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.

Adam Greenbaum, MD, presents late-breaking data at ACC.26.

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel

A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate.

AI model algorithm tablet digital patient data

FDA clears new AI model for pulmonary hypertension

The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.

Medical malpractice gavel diagnostic error mistake stethoscope

Patient injected with acid instead of saline earns undisclosed settlement

The disturbing case highlights a series of process errors and cost-cutting measures that ultimately led to the “never event” accident.

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26

Catheter-based treatment linked to major benefits for intermediate-risk PE

New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.

FDA sees promise in voice-based AI model for heart failure

An advanced algorithm that looks for signs of heart failure in five-second voice recordings has received the FDA's breakthrough device designation.

Medtronic’s MiniMed 780G automated insulin delivery system

Software errors lead to major insulin pump recall—manufacturer shares a fix

Nearly 27,000 MiniMed 780G insulin pumps were included in a new Class II recall. By taking a few basic steps, however, patients should be able to avoid any significant risks.

William P. Shutze, MD, FACS, secretary of the Society of Vascular Surgery (SVS), a vascular surgeon with Texas Vascular Associates in Plano, Texas, and a clinical associate professor of medicine at Texas A&M College of Medicine, explained the role of vascular surgeons in peripheral artery disease (PAD) and critical limb ischemia (CLI).

Getting vascular surgeons more involved leads to key improvements for PAD patients

Vascular surgeons perform procedures interventional cardiologists and interventional radiologists do not do—so why not make sure they are part of every heart team conversation?